rs12592307

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000275.3(OCA2):​c.2364G>A​(p.Ser788Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.222 in 1,612,506 control chromosomes in the GnomAD database, including 46,174 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4160 hom., cov: 32)
Exomes 𝑓: 0.22 ( 42014 hom. )

Consequence

OCA2
NM_000275.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.606

Publications

25 publications found
Variant links:
Genes affected
OCA2 (HGNC:8101): (OCA2 melanosomal transmembrane protein) This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
OCA2 Gene-Disease associations (from GenCC):
  • oculocutaneous albinism type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 15-27845027-C-T is Benign according to our data. Variant chr15-27845027-C-T is described in ClinVar as Benign. ClinVar VariationId is 255730.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.606 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.546 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OCA2NM_000275.3 linkc.2364G>A p.Ser788Ser synonymous_variant Exon 23 of 24 ENST00000354638.8 NP_000266.2 Q04671-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OCA2ENST00000354638.8 linkc.2364G>A p.Ser788Ser synonymous_variant Exon 23 of 24 1 NM_000275.3 ENSP00000346659.3 Q04671-1
OCA2ENST00000353809.9 linkc.2292G>A p.Ser764Ser synonymous_variant Exon 22 of 23 1 ENSP00000261276.8 Q04671-2

Frequencies

GnomAD3 genomes
AF:
0.210
AC:
31785
AN:
151700
Hom.:
4157
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.424
Gnomad AMR
AF:
0.331
Gnomad ASJ
AF:
0.313
Gnomad EAS
AF:
0.563
Gnomad SAS
AF:
0.311
Gnomad FIN
AF:
0.255
Gnomad MID
AF:
0.237
Gnomad NFE
AF:
0.193
Gnomad OTH
AF:
0.212
GnomAD2 exomes
AF:
0.277
AC:
69666
AN:
251336
AF XY:
0.274
show subpopulations
Gnomad AFR exome
AF:
0.107
Gnomad AMR exome
AF:
0.449
Gnomad ASJ exome
AF:
0.320
Gnomad EAS exome
AF:
0.564
Gnomad FIN exome
AF:
0.240
Gnomad NFE exome
AF:
0.198
Gnomad OTH exome
AF:
0.261
GnomAD4 exome
AF:
0.223
AC:
325647
AN:
1460688
Hom.:
42014
Cov.:
33
AF XY:
0.225
AC XY:
163383
AN XY:
726708
show subpopulations
African (AFR)
AF:
0.101
AC:
3381
AN:
33470
American (AMR)
AF:
0.435
AC:
19457
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.324
AC:
8473
AN:
26124
East Asian (EAS)
AF:
0.586
AC:
23266
AN:
39686
South Asian (SAS)
AF:
0.312
AC:
26875
AN:
86206
European-Finnish (FIN)
AF:
0.232
AC:
12367
AN:
53416
Middle Eastern (MID)
AF:
0.267
AC:
1539
AN:
5766
European-Non Finnish (NFE)
AF:
0.194
AC:
215820
AN:
1110956
Other (OTH)
AF:
0.240
AC:
14469
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
11934
23869
35803
47738
59672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7860
15720
23580
31440
39300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.209
AC:
31805
AN:
151818
Hom.:
4160
Cov.:
32
AF XY:
0.219
AC XY:
16240
AN XY:
74182
show subpopulations
African (AFR)
AF:
0.111
AC:
4576
AN:
41362
American (AMR)
AF:
0.332
AC:
5066
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.313
AC:
1087
AN:
3468
East Asian (EAS)
AF:
0.563
AC:
2901
AN:
5152
South Asian (SAS)
AF:
0.311
AC:
1494
AN:
4804
European-Finnish (FIN)
AF:
0.255
AC:
2677
AN:
10506
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.193
AC:
13099
AN:
67942
Other (OTH)
AF:
0.213
AC:
449
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1173
2346
3518
4691
5864
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.203
Hom.:
5022
Bravo
AF:
0.214
Asia WGS
AF:
0.416
AC:
1446
AN:
3478
EpiCase
AF:
0.216
EpiControl
AF:
0.209

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Jun 20, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tyrosinase-positive oculocutaneous albinism Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
0.11
DANN
Benign
0.54
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12592307; hg19: chr15-28090173; COSMIC: COSV62341615; API